Stock Track | Centessa Pharmaceuticals Plunges After Announcing $150M Public Offering

Stock Track09-12

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA) plummeted by 5.76% on Tuesday after the company announced a proposed public offering of $150 million worth of American Depositary Shares (ADSs), each representing one ordinary share.

The biopharmaceutical company stated that it intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of ADSs offered in the public offering. Following the announcement, CNTA's stock price dropped by 4.2% in after-hours trading.

Public offerings are often seen as a dilutive event for existing shareholders, as they increase the total number of outstanding shares, leading to a decrease in the stock's value. Investors may have reacted negatively to the proposed offering, resulting in the significant plunge in CNTA's share price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1124816868?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-12 04:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124816868","market":"hk","top_or_hot":-1,"title":"Stock Track | Centessa Pharmaceuticals Plunges After Announcing $150M Public Offering","media":"Stock Track","content":"<p>Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA) plummeted by 5.76% on Tuesday after the company announced a proposed public offering of $150 million worth of American Depositary Shares (ADSs), each representing one ordinary share.</p>\n\n<p>The biopharmaceutical company stated that it intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of ADSs offered in the public offering. Following the announcement, CNTA's stock price dropped by 4.2% in after-hours trading.</p>\n\n<p>Public offerings are often seen as a dilutive event for existing shareholders, as they increase the total number of outstanding shares, leading to a decrease in the stock's value. Investors may have reacted negatively to the proposed offering, resulting in the significant plunge in CNTA's share price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Centessa Pharmaceuticals Plunges After Announcing $150M Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Centessa Pharmaceuticals Plunges After Announcing $150M Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n2024-09-12 04:48 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA) plummeted by 5.76% on Tuesday after the company announced a proposed public offering of $150 million worth of American Depositary Shares (ADSs), ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CNTA","symbol_name":"Centessa Pharmaceuticals plc","start_time":0,"source_url":"","article_id":"1124816868","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124816868","pubTimestamp":1726087707,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Centessa Pharmaceuticals plc  plummeted by 5.76% on Tuesday after the company announced a proposed public offering of $150 million worth of American Depositary Shares , each representing one ordinary share.The biopharmaceutical company stated that it intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of ADSs offered in the public offering. Following the announcement, CNTA's stock price dropped by 4.2% in after-hours trading.Public offerings ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CNTA":"Centessa Pharmaceuticals plc"},"translate_title":"Centessa Pharmaceuticals宣布公开发行1.5亿美元后股价暴跌","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNTA":1},"content_text":"Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA) plummeted by 5.76% on Tuesday after the company announced a proposed public offering of $150 million worth of American Depositary Shares (ADSs), each representing one ordinary share.\nThe biopharmaceutical company stated that it intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of ADSs offered in the public offering. Following the announcement, CNTA's stock price dropped by 4.2% in after-hours trading.\nPublic offerings are often seen as a dilutive event for existing shareholders, as they increase the total number of outstanding shares, leading to a decrease in the stock's value. Investors may have reacted negatively to the proposed offering, resulting in the significant plunge in CNTA's share price.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124816868"}